English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background Patients older than 80 years old were excluded from participation in the large controlled randomized trials that demonstrated the efficacy of carotid endarterectomy (CEA) in preventing stroke in selected symptomatic and asymptomatic patients. Because of limited longevity and perceived increased perioperative risk from CEA, alternative treatment options, such as carotid angioplasty and stenting (CAS) have been suggested as a lower-risk alternatives. Many of the reports evaluating CAS have thus used age older than 80 years as one of the high-risk criteria allowing entry into the studies. We analyzed 30-day stroke and death rates after CEA in patients aged 80 or more with severe symptomatic and asymptomatic carotid disease.

bmc geriatrics

Octogenarians and nonagenarians with severe symptomatic and asymptomatic carotid disease: does older age indicate "high risk" for carotid endarterectomy?